헬스케어 연합학습 시장 : 컴포넌트, 도입 모드, 학습 아키텍처, 협업 모델, 데이터 모달리티, 용도, 지역별 - 규모, 업계 역학, 기회 분석 및 예측(2026-2035년)

The global federated learning in healthcare market is witnessing rapid and transformative growth, driven by the increasing demand for secure, privacy-preserving artificial intelligence technologies across the healthcare industry. The market was valued at approximately USD 35.12 million in 2025 and is projected to reach nearly USD 158.3 million by 2035, expanding at a compound annual growth rate (CAGR) of 16.25% during the forecast period from 2026 to 2035. This substantial growth trajectory reflects the rising adoption of decentralized machine learning frameworks that enable healthcare organizations to collaboratively utilize large-scale medical datasets without directly exposing sensitive patient information.

One of the primary factors driving market expansion is the growing need for collaborative healthcare artificial intelligence systems that can operate effectively without compromising patient privacy and data security. Traditional centralized data-sharing models often require healthcare organizations to transfer confidential patient records into unified repositories, increasing the risk of data breaches, unauthorized access, and regulatory non-compliance. Federated learning overcomes these challenges by enabling artificial intelligence models to train locally within institutional infrastructures while only exchanging encrypted model updates rather than raw patient data.

Noteworthy Market Developments

The competitive landscape of the federated learning in healthcare market is characterized by the strong presence of several major technology and healthcare organizations that currently dominate the commercial medical artificial intelligence space. These companies maintain leadership positions through extensive investments in decentralized computing infrastructure, advanced machine learning technologies, secure healthcare analytics platforms, and strategic partnerships with hospitals, pharmaceutical firms, and research institutions.

NVIDIA has emerged as one of the most dominant players in the global healthcare federated learning ecosystem due to its unparalleled computational hardware infrastructure and highly advanced proprietary collaborative artificial intelligence software frameworks. Owkin has secured a significant position within the federated learning in healthcare market through extensive partnerships with major pharmaceutical corporations, biotechnology firms, and clinical research organizations.

Siemens Healthineers maintains substantial influence in the healthcare federated learning market through its extensive control of global diagnostic imaging networks and advanced medical technology ecosystems.GE HealthCare continues to expand its role within the decentralized healthcare intelligence sector by leveraging its vast global network of hospital hardware installations and healthcare technology platforms.

FedML has captured considerable market value by offering highly specialized decentralized machine learning tools specifically designed to protect sensitive healthcare parameters and optimize federated training environments. These leading organizations justify their dominant market positions by actively establishing foundational interoperability standards and decentralized artificial intelligence frameworks that are now widely utilized across the healthcare industry.

Core Growth Drivers

Consumer groups and healthcare stakeholders within the emerging decentralized collaborative diagnostic industry are increasingly demanding immediate and highly reliable privacy-focused solutions for medical data management. As healthcare systems continue to digitize patient records, diagnostic imaging, genomic information, and clinical research datasets, concerns regarding unauthorized access, data misuse, and cybersecurity threats have intensified significantly. Patients are becoming more aware of the risks associated with centralized healthcare databases, particularly as large-scale healthcare data breaches continue to expose sensitive medical information worldwide. This growing awareness has accelerated demand for federated learning technologies that prioritize decentralized data processing and enhanced patient confidentiality while still enabling advanced artificial intelligence-driven healthcare innovation.

Emerging Opportunity Trends

Increasingly strict data localization regulations across multiple countries and healthcare jurisdictions are compelling clinics, hospitals, and medical research organizations to adopt fully decentralized artificial intelligence training paradigms. Governments and regulatory authorities worldwide continue implementing stronger restrictions on cross-border healthcare data transfers to protect patient privacy and national data sovereignty. These evolving regulatory frameworks make centralized healthcare data aggregation increasingly difficult and costly for multinational healthcare organizations. Consequently, federated learning has emerged as a highly attractive alternative, enabling institutions to comply with regional data localization requirements while still participating in global collaborative artificial intelligence initiatives. This shift toward decentralized healthcare analytics is expected to play a central role in shaping the future growth and technological evolution of the federated learning in healthcare market.

Barriers to Optimization

The requirement for substantial financial investment in technological infrastructure represents one of the major challenges that may restrain the growth of federated learning in healthcare market. Implementing federated learning systems within healthcare environments demands extensive spending on advanced computational hardware, secure networking frameworks, cloud integration platforms, and specialized artificial intelligence software solutions. Healthcare organizations must also invest in high-performance servers, encrypted communication channels, distributed data management systems, and cybersecurity technologies to ensure secure and efficient decentralized model training. These infrastructure requirements can create significant financial pressure, particularly for smaller hospitals, regional healthcare providers, and institutions operating within limited budget environments.

Detailed Market Segmentation

By application, the drug discovery and development segment captured the largest share of the federated learning in healthcare market, reflecting the increasing reliance of pharmaceutical and biotechnology companies on decentralized artificial intelligence technologies. This segment emerged as the leading revenue contributor due to the growing need for secure collaborative research environments capable of accelerating complex therapeutic development processes while maintaining strict protection of proprietary scientific data.

By component, specialized software platforms accounted for the dominant share of the federated learning in healthcare market, driven by the growing demand for advanced artificial intelligence coordination systems and secure distributed data management capabilities. These software solutions serve as the operational foundation of federated learning environments, enabling healthcare organizations to efficiently manage decentralized model training, secure communication protocols, and collaborative analytical workflows across multiple institutions.

By data modality, medical imaging files have emerged as the most widely utilized analytical format within the healthcare federated learning ecosystem. These visual datasets play a critical role in the development and deployment of advanced artificial intelligence systems, particularly in areas involving disease diagnosis, clinical imaging interpretation, and predictive healthcare analytics. Medical imaging assets such as magnetic resonance imaging scans, computed tomography images, X-rays, and ultrasound records dominate federated learning implementations due to their high clinical value and their suitability for computer vision applications.

• Based on the collaboration model, cross-silo federated architectures have emerged as the dominant approach in federated learning healthcare market deployments. These architectures primarily operate through coordinated collaborations among hospitals, healthcare networks, research institutions, and diagnostic laboratories, enabling multiple organizations to jointly train artificial intelligence models without directly sharing sensitive patient data. The growing preference for cross-silo systems is largely driven by the healthcare sector's strong emphasis on privacy protection, regulatory compliance, and secure institutional collaboration.

Segment Breakdown

By Component

• Software Platforms
• Infrastructure Solutions
• Services
• Consulting Services
• Integration & Deployment Services
• Support & Maintenance Services
• Training Services

By Deployment Mode

• Cloud-based
• On-premises
• Hybrid

By Learning Architecture

• Horizontal Federated Learning
• Vertical Federated Learning
• Federated Transfer Learning

By Collaboration Model

• Cross-silo Federated Learning
• Cross-device Federated Learning

By Data Modality

• Medical Imaging Data
• Electronic Health Records (EHR) Data
• Genomic Data
• Wearable & Remote Monitoring Data
• Pathology Data
• Clinical Trial Data
• Multi-modal Healthcare Data

By Application

• Medical Imaging & Diagnostics
• Drug Discovery & Development
• Clinical Decision Support
• Remote Patient Monitoring
• Precision Medicine
• Population Health Management
• Predictive Analytics
• Clinical Research
• Disease Risk Prediction
• Healthcare Operations Optimization

By Technology Integration

• Differential Privacy-enabled Systems
• Secure Multi-party Computation-enabled Systems
• Blockchain-integrated Federated Learning
• Edge AI-enabled Federated Learning

By End User

• Hospitals & Health Systems
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutions
• Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Government & Public Health Agencies

By Enterprise Size

• Large Enterprises
• Small & Medium-sized Enterprises (SMEs)

By Use Environment

• Clinical Care Environments
• Research Environments
• Multi-institutional Healthcare Networks

By Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA
• South America
• Argentina
• Brazil
• Rest of South America

Geography Breakdown

• North America emerged as the dominant force in the global market, accounting for an impressive thirty-five percent of the overall market share. Healthcare investment, artificial intelligence infrastructure, and advanced digital healthcare ecosystems have all contributed to the region's leadership position.
• The United States has played a particularly influential role in driving market expansion through proactive regulatory encouragement and policy support for privacy-preserving machine learning innovations. Regulatory authorities have increasingly promoted the development of secure artificial intelligence frameworks that allow healthcare organizations to exchange insights without directly exposing sensitive patient data.

Leading Market Participants

• GE HealthCare Technologies, Inc.
• Google LLC (Alphabet Inc.)
• IBM Corporation
• Microsoft Corporation
• Siemens Healthineers AG (Siemens AG)
• Medtronic PLC
• NVIDIA Corporation
• Intel Corporation
• Health Catalyst, Inc.
• Owkin
• Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Federated Learning in Healthcare Market

Chapter 2. Research Methodology & Research Framework

• 2.1. Research Objective
• 2.2. Product Overview
• 2.3. Market Segmentation
• 2.4. Qualitative Research
  • 2.4.1. Primary & Secondary Sources
• 2.5. Quantitative Research
  • 2.5.1. Primary & Secondary Sources
• 2.6. Breakdown of Primary Research Respondents, By Region
• 2.7. Assumption for Study
• 2.8. Market Size Estimation
• 2.9. Data Triangulation

Chapter 3. Global Federated Learning in Healthcare Market Overview

• 3.1. Industry Value Chain Analysis
  • 3.1.1. Hardware & Edge Compute Infrastructure Providers (GPUs, Servers, Edge Devices)
  • 3.1.2. Cloud & Hybrid Infrastructure Providers
  • 3.1.3. Federated Learning Platform & Framework Developers
  • 3.1.4. Privacy-Preserving Technology Providers (Differential Privacy, SMPC, Blockchain)
  • 3.1.5. Integration, Orchestration & Implementation Service Providers
  • 3.1.6. Healthcare Networks (Hospitals, Pharma, CROs, Research Institutions)
  • 3.1.7. End Users (Clinicians, Researchers, Drug Developers, Public Health Agencies)
• 3.2. Industry Outlook
  • 3.2.1. Overview of AI in Healthcare & Privacy-Preserving Machine Learning
  • 3.2.2. Regulatory Landscape (HIPAA, GDPR, FDA AI/ML Guidance, EU AI Act, Data Localization Laws)
• 3.3. PESTLE Analysis
• 3.4. Porter's Five Forces Analysis
  • 3.4.1. Bargaining Power of Suppliers
  • 3.4.2. Bargaining Power of Buyers
  • 3.4.3. Threat of Substitutes
  • 3.4.4. Threat of New Entrants
  • 3.4.5. Degree of Competition
• 3.5. Market Growth and Outlook
  • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
  • 3.5.2. Price Trend Analysis, By Component

Chapter 4. Global Federated Learning in Healthcare Market Analysis

• 4.1. Competition Dashboard
  • 4.1.1. Market Concentration Rate
  • 4.1.2. Company Market Share Analysis (Value %), 2025
  • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Federated Learning in Healthcare Market Analysis

• 5.1. Market Dynamics and Trends
  • 5.1.1. Growth Drivers
  • 5.1.2. Restraints
  • 5.1.3. Opportunity
  • 5.1.4. Key Trends
• 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 5.2.1. By Component
    • 5.2.1.1. Key Insights
      • 5.2.1.1.1. Software Platforms
      • 5.2.1.1.2. Infrastructure Solutions
      • 5.2.1.1.3. Services
        • 5.2.1.1.3.1. Consulting Services
        • 5.2.1.1.3.2. Integration & Deployment Services
        • 5.2.1.1.3.3. Support & Maintenance Services
        • 5.2.1.1.3.4. Training Services
  • 5.2.2. By Deployment Mode
    • 5.2.2.1. Key Insights
      • 5.2.2.1.1. Cloud-based
      • 5.2.2.1.2. On-premises
      • 5.2.2.1.3. Hybrid
  • 5.2.3. By Learning Architecture
    • 5.2.3.1. Key Insights
      • 5.2.3.1.1. Horizontal Federated Learning
      • 5.2.3.1.2. Vertical Federated Learning
      • 5.2.3.1.3. Federated Transfer Learning
  • 5.2.4. By Collaboration Model
    • 5.2.4.1. Key Insights
      • 5.2.4.1.1. Cross-silo Federated Learning
      • 5.2.4.1.2. Cross-device Federated Learning
  • 5.2.5. By Data Modality
    • 5.2.5.1. Key Insights
      • 5.2.5.1.1. Medical Imaging Data
      • 5.2.5.1.2. Electronic Health Records (EHR) Data
      • 5.2.5.1.3. Genomic Data
      • 5.2.5.1.4. Wearable & Remote Monitoring Data
      • 5.2.5.1.5. Pathology Data
      • 5.2.5.1.6. Clinical Trial Data
      • 5.2.5.1.7. Multi-modal Healthcare Data
  • 5.2.6. By Application
    • 5.2.6.1. Key Insights
      • 5.2.6.1.1. Medical Imaging & Diagnostics
      • 5.2.6.1.2. Drug Discovery & Development
      • 5.2.6.1.3. Clinical Decision Support
      • 5.2.6.1.4. Remote Patient Monitoring
      • 5.2.6.1.5. Precision Medicine
      • 5.2.6.1.6. Population Health Management
      • 5.2.6.1.7. Predictive Analytics
      • 5.2.6.1.8. Clinical Research
      • 5.2.6.1.9. Disease Risk Prediction
      • 5.2.6.1.10. Healthcare Operations Optimization
  • 5.2.7. By Technology Integration
    • 5.2.7.1. Key Insights
      • 5.2.7.1.1. Differential Privacy-enabled Systems
      • 5.2.7.1.2. Secure Multi-party Computation-enabled Systems
      • 5.2.7.1.3. Blockchain-integrated Federated Learning
      • 5.2.7.1.4. Edge AI-enabled Federated Learning
  • 5.2.8. By End User
    • 5.2.8.1. Key Insights
      • 5.2.8.1.1. Hospitals & Health Systems
      • 5.2.8.1.2. Pharmaceutical & Biotechnology Companies
      • 5.2.8.1.3. Research & Academic Institutions
      • 5.2.8.1.4. Diagnostic Laboratories
      • 5.2.8.1.5. Contract Research Organizations (CROs)
      • 5.2.8.1.6. Government & Public Health Agencies
  • 5.2.9. By Enterprise Size
    • 5.2.9.1. Key Insights
      • 5.2.9.1.1. Large Enterprises
      • 5.2.9.1.2. Small & Medium-sized Enterprises (SMEs)
  • 5.2.10. By Use Environment
    • 5.2.10.1. Key Insights
      • 5.2.10.1.1. Clinical Care Environments
      • 5.2.10.1.2. Research Environments
      • 5.2.10.1.3. Multi-institutional Healthcare Networks
  • 5.2.11. By Region
    • 5.2.11.1. Key Insights
      • 5.2.11.1.1. North America
        • 5.2.11.1.1.1. The U.S.
        • 5.2.11.1.1.2. Canada
        • 5.2.11.1.1.3. Mexico
      • 5.2.11.1.2. Europe
        • 5.2.11.1.2.1. Western Europe
          • 5.2.11.1.2.1.1. The UK
          • 5.2.11.1.2.1.2. Germany
          • 5.2.11.1.2.1.3. France
          • 5.2.11.1.2.1.4. Italy
          • 5.2.11.1.2.1.5. Spain
          • 5.2.11.1.2.1.6. Rest of Western Europe
        • 5.2.11.1.2.2. Eastern Europe
          • 5.2.11.1.2.2.1. Poland
          • 5.2.11.1.2.2.2. Russia
          • 5.2.11.1.2.2.3. Rest of Eastern Europe
      • 5.2.11.1.3. Asia Pacific
        • 5.2.11.1.3.1. China
        • 5.2.11.1.3.2. India
        • 5.2.11.1.3.3. Japan
        • 5.2.11.1.3.4. South Korea
        • 5.2.11.1.3.5. Australia & New Zealand
        • 5.2.11.1.3.6. ASEAN
          • 5.2.11.1.3.6.1. Cambodia
          • 5.2.11.1.3.6.2. Indonesia
          • 5.2.11.1.3.6.3. Malaysia
          • 5.2.11.1.3.6.4. Philippines
          • 5.2.11.1.3.6.5. Singapore
          • 5.2.11.1.3.6.6. Thailand
          • 5.2.11.1.3.6.7. Vietnam
          • 5.2.11.1.3.6.8. Rest of ASEAN
        • 5.2.11.1.3.7. Rest of Asia Pacific
      • 5.2.11.1.4. Middle East & Africa
        • 5.2.11.1.4.1. UAE
        • 5.2.11.1.4.2. Saudi Arabia
        • 5.2.11.1.4.3. South Africa
        • 5.2.11.1.4.4. Rest of MEA
      • 5.2.11.1.5. South America
        • 5.2.11.1.5.1. Argentina
        • 5.2.11.1.5.2. Brazil
        • 5.2.11.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

• 6.1. Market Dynamics and Trends
  • 6.1.1. Growth Drivers
  • 6.1.2. Restraints
  • 6.1.3. Opportunity
  • 6.1.4. Key Trends
• 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 6.2.1. Key Insights
    • 6.2.1.1. By Component
    • 6.2.1.2. By Deployment Mode
    • 6.2.1.3. By Learning Architecture
    • 6.2.1.4. By Collaboration Model
    • 6.2.1.5. By Data Modality
    • 6.2.1.6. By Application
    • 6.2.1.7. By Technology Integration
    • 6.2.1.8. By End User
    • 6.2.1.9. By Enterprise Size
    • 6.2.1.10. By Use Environment
    • 6.2.1.11. By Country

Chapter 7. Europe Market Analysis

• 7.1. Market Dynamics and Trends
  • 7.1.1. Growth Drivers
  • 7.1.2. Restraints
  • 7.1.3. Opportunity
  • 7.1.4. Key Trends
• 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 7.2.1. Key Insights
    • 7.2.1.1. By Component
    • 7.2.1.2. By Deployment Mode
    • 7.2.1.3. By Learning Architecture
    • 7.2.1.4. By Collaboration Model
    • 7.2.1.5. By Data Modality
    • 7.2.1.6. By Application
    • 7.2.1.7. By Technology Integration
    • 7.2.1.8. By End User
    • 7.2.1.9. By Enterprise Size
    • 7.2.1.10. By Use Environment
    • 7.2.1.11. By Country

Chapter 8. Asia Pacific Market Analysis

• 8.1. Market Dynamics and Trends
  • 8.1.1. Growth Drivers
  • 8.1.2. Restraints
  • 8.1.3. Opportunity
  • 8.1.4. Key Trends
• 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 8.2.1. Key Insights
    • 8.2.1.1. By Component
    • 8.2.1.2. By Deployment Mode
    • 8.2.1.3. By Learning Architecture
    • 8.2.1.4. By Collaboration Model
    • 8.2.1.5. By Data Modality
    • 8.2.1.6. By Application
    • 8.2.1.7. By Technology Integration
    • 8.2.1.8. By End User
    • 8.2.1.9. By Enterprise Size
    • 8.2.1.10. By Use Environment
    • 8.2.1.11. By Country

Chapter 9. Middle East & Africa Market Analysis

• 9.1. Market Dynamics and Trends
  • 9.1.1. Growth Drivers
  • 9.1.2. Restraints
  • 9.1.3. Opportunity
  • 9.1.4. Key Trends
• 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 9.2.1. Key Insights
    • 9.2.1.1. By Component
    • 9.2.1.2. By Deployment Mode
    • 9.2.1.3. By Learning Architecture
    • 9.2.1.4. By Collaboration Model
    • 9.2.1.5. By Data Modality
    • 9.2.1.6. By Application
    • 9.2.1.7. By Technology Integration
    • 9.2.1.8. By End User
    • 9.2.1.9. By Enterprise Size
    • 9.2.1.10. By Use Environment
    • 9.2.1.11. By Country

Chapter 10. South America Market Analysis

• 10.1. Market Dynamics and Trends
  • 10.1.1. Growth Drivers
  • 10.1.2. Restraints
  • 10.1.3. Opportunity
  • 10.1.4. Key Trends
• 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 10.2.1. Key Insights
    • 10.2.1.1. By Component
    • 10.2.1.2. By Deployment Mode
    • 10.2.1.3. By Learning Architecture
    • 10.2.1.4. By Collaboration Model
    • 10.2.1.5. By Data Modality
    • 10.2.1.6. By Application
    • 10.2.1.7. By Technology Integration
    • 10.2.1.8. By End User
    • 10.2.1.9. By Enterprise Size
    • 10.2.1.10. By Use Environment
    • 10.2.1.11. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

• 11.1. GE HealthCare Technologies, Inc.
• 11.2. Google LLC (Alphabet Inc.)
• 11.3. Health Catalyst, Inc.
• 11.4. IBM Corporation
• 11.5. Intel Corporation
• 11.6. Medtronic PLC
• 11.7. Microsoft Corporation
• 11.8. NVIDIA Corporation
• 11.9. Owkin
• 11.10. Siemens Healthineers AG (Siemens AG)
• 11.11. Other Prominent Players

Chapter 12. Annexure

• 12.1. List of Secondary Sources
• 12.2. Key Country Markets- Macro Economic Outlook/Indicators